WARSAW, Ind., July 26, 2016 /PRNewswire/ -- Zimmer Biomet
Holdings, Inc. (NYSE and SIX: ZBH), a global leader in
musculoskeletal healthcare, today unveiled Signature
Solutions™, a comprehensive suite of clinical services and
technologies designed to assist hospitals and medical practices to
seamlessly transition to value-based healthcare models by
maintaining excellent patient outcomes, while maximizing procedural
and cost efficiencies across the entire episode of care. Last
year alone, the U.S. launched two major value-based healthcare
mandates, the Comprehensive Care for Joint Replacement (CJR) act
and the Medicare Access and CHIP Reauthorization Act of 2015
(MACRA), and Europe and
Canada have been actively passing
similar policies that base reimbursement on patient and health
economic outcomes.
Signature Solutions had its genesis in the mid-1990s,
when Zimmer Biomet launched its expert consulting services in
response to the evolving global shift toward value-based
healthcare. Since then, the Company has advised more than 450
hospitals and healthcare facilities worldwide on improving the
value of their musculoskeletal programs by providing better care,
lowering costs and increasing the number of patients treated.
Signature Solutions will integrate Zimmer Biomet's
established consulting platform, with a strategically curated suite
of technologies and services, to form a one-of-a-kind offering that
drives improvement across every aspect of the healthcare value
creation equation. Initially, Zimmer Biomet will offer the
comprehensive suite of solutions to musculoskeletal healthcare
service lines at select, academic facilities in the U.S., with a
broader release scheduled for 2017.
"Our 90-year legacy and leadership in musculoskeletal
healthcare, coupled with more than a decade of consulting
experience delivering measurably improved outcomes for large and
small institutions worldwide, gives Zimmer Biomet a deep
understanding of the levers driving success in the value-based
healthcare environment," said David
Dvorak, President and CEO of Zimmer Biomet. "Signature
Solutions will encapsulate our exclusive and extensive
knowledge of the new healthcare landscape into the first end-to-end
suite of clinical services, technologies and proprietary analytical
tools, which are designed to work seamlessly with the institutions'
existing infrastructure to improve quality outcomes, provide more
efficient care and increase provider throughput."
The Signature Solutions offering consists of clinical
services, solutions and technologies cultivated by Zimmer Biomet
through existing and planned strategic partnerships and
acquisitions. The core components of Signature Solutions
will include:
- Interactive and proven patient engagement tools designed to
educate patients about the procedure and treatment options,
facilitate physician-patient communication, and increase patient
adherence to pre-op, intra-op and post-op/rehab protocols.
- Data mining and analysis platform that enables hospitals to
collect critical patient-reported outcomes data (i.e., satisfaction
with care, pain management, facility, etc.) that can factor into
the level of reimbursement provided for each procedure.
- Expert consulting services, digital health software solutions
and personalized, patient-specific medical technologies and
instruments that help hospitals improve patient outcomes, increase
overall productivity and surgical efficiency by streamlining
workflow, and enhance surgical and rehab protocols.
"As patient outcomes figure more prominently in the bundled
payment environment, healthcare institutions are under increased
pressure to minimize inefficiencies along the entire episode of
care while delivering superior quality of care and a positive
patient experience," said Dr. Todd
Dietrick, orthopaedic surgeon at Huntington Memorial
Hospital in Pasadena,
California. "Over the past year, we engaged Signature
Solutions' expert consulting services to guide our clinical and
operational teams to improve the value of our orthopaedic program
by creating standards for patient optimization and surgical
performance. The new technologies and digital software
components will further enhance the utility of Signature
Solutions and provide healthcare institutions with an
all-in-one solution to optimize performance in a value-based care
model."
"We're excited to redefine the meaning of innovation in our
sector with the launch of Signature Solutions, a truly
unique and differentiated offering that successfully leverages our
technological expertise, industry know-how, strategic alliances and
extensive network of institutional relationships," added Mr.
Dvorak. "We look forward to a broad-scale launch of Signature
Solutions timed to coincide with institutions seeking ways to
redesign care protocols and identify potential cost saving
opportunities in the new bundled payment environment."
For more information about Signature Solutions, visit
www.zbsignaturesolutions.com
About the Company
Founded in 1927 and headquartered in
Warsaw, Indiana, Zimmer Biomet is
a global leader in musculoskeletal healthcare. We design,
manufacture and market orthopaedic reconstructive products; sports
medicine, biologics, extremities and trauma products; spine, bone
healing, craniomaxillofacial and thoracic products; dental
implants; and related surgical products.
We collaborate with healthcare professionals around the globe to
advance the pace of innovation. Our products and solutions
help treat patients suffering from disorders of, or injuries to,
bones, joints or supporting soft tissues. Together with
healthcare professionals, we help millions of people live better
lives.
We have operations in more than 25 countries around the world
and sell products in more than 100 countries. For more
information, visit www.zimmerbiomet.com, or follow Zimmer Biomet on
Twitter at www.twitter.com/zimmerbiomet.
Cautionary Statement Regarding Forward-Looking
Statements
This news release contains forward-looking statements within
the meaning of the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements
include, but are not limited to, statements concerning Zimmer
Biomet's expectations, plans, prospects, and product and service
offerings, including new product launches and potential clinical
successes. Such statements are based upon the current beliefs
and expectations of management and are subject to significant risks
and uncertainties that could cause actual outcomes and results to
differ materially. For a list and description of some of such
risks and uncertainties, see our periodic reports filed with the
SEC. These factors should not be construed as exhaustive and
should be read in conjunction with the other cautionary statements
that are included in Zimmer Biomet's filings with the SEC. We
disclaim any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as may be set forth in our
periodic reports. Accordingly, such forward-looking
statements speak only as of the date made. Readers of this
news release are cautioned not to place undue reliance on these
forward-looking statements, since, while management believes the
assumptions on which the forward-looking statements are based are
reasonable, there can be no assurance that these forward-looking
statements will prove to be accurate. This cautionary
statement is applicable to all forward-looking statements contained
in this news release.
Logo - http://photos.prnewswire.com/prnh/20150624/225371LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/zimmer-biomet-unveils-signature-solutions-300303747.html
SOURCE Zimmer Biomet Holdings, Inc.